Hormone Therapy News

When hormone therapy is initiated close to the start of menopause in healthy women without diabetes, it does not appear to be associated with any cognitive harm, according to data presented at the 2018 Alzheimer’s Association International Conference.

When combined with sotalol, the oral contraceptive drospirenone was associated with QTc prolongation, a marker for torsades de pointes, according to new findings.

The use of single- or multi-item measures in population surveys may serve as a useful tool to better account for adults with disorders of sex development or intersex identity, according to research published in LGBT Health.

WASHINGTON — There is a “durable, biological underpinning” to gender identity that should be considered in any policy determinations that impact transgender people, including antidiscrimination legislation and the coverage of medically necessary treatments for gender incongruence, according to several speakers at an Endocrine Society congressional briefing on transgender health.

Menopausal women who discontinued low doses of hormone therapy did not experience accelerated changes in carotid artery intima-media thickness during 3 years of observation, according to follow-up analysis of a study published in Menopause.

Among transgender adolescents, a longer delay between the recognition of transgender identity and the initiation of cross-sex hormone therapy is independently associated with an increased risk for current and lifetime smoking, according to findings published in Transgender Health.

In childhood cancer survivors, treatment with growth hormone was associated with gains in height vs. untreated control patients without increased risk for diabetes or secondary tumors, according to a meta-analysis published in The Journal of Clinical Endocrinology & Metabolism.

Transgender women who initiated cross-sex estrogen therapy were at increased risk for acute cardiovascular events, including venous thromboembolism and stroke, compared with cisgender women who initiated similar hormone therapy, according to a health care database analysis published in the Annals of Internal Medicine.

ORLANDO, Fla. — Among men with hypogonadism included in a urology registry, long-term treatment with testosterone may lead to remission of type 2 diabetes, according to a speaker.

Substantial strides have been made in physician education and cultural competency in caring for transgender patients, but gaps remain in the areas of familiarity and comfort with this population, according to Joshua D. Safer, MD, executive director of the Mount Sinai Center for Transgender Medicine and Surgery and senior faculty member at the Icahn School of Medicine at Mount Sinai.